Impact of Medtronic’s Fidelis ICD Lead Recall
A Survey of Fifty-two Electrophysiologists
Study Description
|
Topic |
Reactions to Medtronic’s October 15, 2007 recall of its Fidelis implantable cardioverter defibrillator (ICD) leads |
|
Respondent Type |
Physicians |
|
Specialties Covered |
Electrophysiology |
|
Region |
United States Only |
|
Methodology |
Online survey, self-administered via a Panel Intelligence website Duration: 15 minutes Size: 52 Fielding Dates: October 29, 2007 to October 30, 2007 |
Objectives
To understand and quantify the impact of Medtronic’s October 2007 recall of its Sprint Fidelis family of ICD leads by surveying a set of U.S.-based electrophysiologists.
§ Anticipate trends in ICD usage this quarter and over the next one to 5 years.
§ Estimate ICD brand shares pre- and post-recall.
§ Determine drivers of change in initial ICD implant volumes.
§ Understand impact of recall on physician perceptions of Medtronic.
§ Identify clinical implications of recall in terms of replacement leads used and explantation practices.
§ Determine impact, if any, of recall on usage of remote patient monitoring systems.
Companies and Products Mentioned in This Report
|
Company |
Ticker Symbol |
Product(s) |
|
Medtronic |
MDT |
Sprint Fidelis, Carelink, Quattro |
|
St. Jude Medical, Inc. |
STJ |
Riata, Housecall |
|
Boston Scientific Corp. |
BSX |
Reliance, Latitude |
|
Biotronik |
[Private] |
None mentioned [limited coverage] |
Inclusion Criteria and Respondent Demographics
|
Inclusion Criteria
|
§ Board-certified electrophysiologist § In practice between 2 and 30 years § Spends at least 75% of professional time in clinical practice § Performs at least 10 ICD implants per month |
| © Panel Intelligence, LLC. 1999-2008. All rights reserved. A wholly owned subsidiary of MCF Corporation (NASDAQ: MERR) Privacy Policy |